Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Shares Issued (2016 - 2025)

Northwest Biotherapeutics' Shares Issued history spans 16 years, with the latest figure at -$17.3 million for Q4 2025.

  • Quarterly results put Shares Issued at -$17.3 million for Q4 2025, down 236.04% from a year ago — trailing twelve months through Dec 2025 was $23000.0 (down 99.84% YoY), and the annual figure for FY2025 was $23000.0, down 99.84%.
  • Shares Issued for Q4 2025 was -$17.3 million at Northwest Biotherapeutics, down from $4.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $12.7 million in Q4 2024 to a low of -$17.3 million in Q4 2025.
  • The 5-year median for Shares Issued is $1.3 million (2023), against an average of $2.4 million.
  • Peak annual rise in Shares Issued hit 18746.15% in 2025, while the deepest fall reached 236.04% in 2025.
  • Year by year, Shares Issued stood at $7.9 million in 2021, then plummeted by 85.78% to $1.1 million in 2022, then tumbled by 89.37% to $119000.0 in 2023, then skyrocketed by 10572.27% to $12.7 million in 2024, then plummeted by 236.04% to -$17.3 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$17.3 million, $4.9 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.